PMV Pharma Updates Rezatapopt Data In PYNNACLE Ph2 Trial
24 Oct 2025 //
GLOBENEWSWIRE
PMV Pharma To Present Rezatapopt Ph 2 Data at AACR-NCI-EORTC
13 Oct 2025 //
GLOBENEWSWIRE
PMV Reveals Positive Rezatapopt Data From Ph 2 TP53 Y220C Trial
10 Sep 2025 //
GLOBENEWSWIRE
PMV Pharma Reports Q2 2024 Results And PYNNACLE Trial Update
08 Aug 2024 //
GLOBENEWSWIRE
Foundation Medicine, PMV Pharma CDx Tie-Up For p53 Reactivator
29 May 2024 //
BUSINESSWIRE
Foundation Medicine, PMV Pharma Develop CDx For p53 Reactivator
29 May 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support